Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 9.69 | 22.15 |
PEG Ratio (TTM) | -0.37 | 10.59 |
P/S Ratio (TTM) | 1.40 | 4.15 |
P/B Ratio (TTM) | 1.72 | 4.82 |
P/FCF Ratio (TTM) | -60.04 | 24.81 |
Price to 5YR AVG Earnings Ratio | -1.79 | 55.27 |
Price to 5YR AVG FCF Ratio | -0.61 | 45.46 |
Profitability (50%) |
Company | Industry |
---|---|---|
ROA (TTM) | 12.42% | -51.70% |
ROE (TTM) | 18.69% | -4.47% |
Net Profit Margin (TTM) | 9.92% | 4.52% |
ROIC 5YR AVG | -29.76% | 16.92% |
Growth (53%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 116.15% | 11.62% | 26.76% |
Revenue | 41.40% | -14.00% | 2.78% |
Net Income | 41.33% | 7.36% | 27.90% |
Cash Flow | -113.58% | -63.74% | -35.83% |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.12 | 2.20 |
Quick Ratio (TTM) | 1.40 | 1.52 |
D/E Ratio (TTM) | 0.06 | 0.61 |
Interest Coverage (TTM) | 3.94 | 4.43 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | N/A | 5.86 |
LTL to 5YR AVG FCF | -0.07 | 4.46 |
Shares Outstanding Growth 5YR AVG | 3.10% | 0.49% |